Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression Analysis of Urinary Exosome miR-142-3p in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value

NCT06097351 is registered in ClinicalTrials.gov with Yipeng Liu as lead sponsor.

NCT NCT06097351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06097351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression Analysis of Urinary Exosome miR-142-3p in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value
Lead sponsor
Yipeng Liu
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2020
Completion date
January 31, 2024
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy